Haermonics Overview

  • Status
  • Private
  • Employees
  • 4
  • Latest Deal Type
  • Later Stage VC
  • Investors
  • 5

Haermonics General Information


Developer of a postoperative surgical drainage technology designed to offer a cleaner and safer open-heart surgery. The company's system flushes and drains the pericardial space with a warm saline solution for stop bleeding, enabling physicians to improve safety of surgeries as well as reduce blood transfusion amount and medical expenses.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Primary Office
  • Amsterdam Health Technology Centre
  • Paasheuvelweg 25, Wing 5D
  • 1105 BP Amsterdam
  • Netherlands
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Haermonics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 25-May-2020 Completed Generating Revenue
3. Early Stage VC Completed Startup
2. Accelerator/Incubator Completed Startup
1. Grant 28-May-2015 $112K Completed Startup

Haermonics Executive Team (4)

Name Title Board Seat Contact Info
Wouter Markus Chief Executive Officer
Roland Zegger Interim Chief Executive Officer
David Koolbergen Chief Medical Officer & Co-Founder
Johan Manshanden Co-Founder, CSO

Haermonics Investors (5)

To view Haermonics‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Brabantse Ontwikkelings Maatschappij Venture Capital Minority 000 0000 000000 0
GAP Technology holding Family Office Minority 000 0000 000000 0
ACE Venture Lab Accelerator/Incubator 000 0000 000000 0
NLC Accelerator/Incubator Minority 000 0000 000000 0
UvA Ventures Holding Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial